Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
none assigned
|
| gptkbp:CASNumber |
1353859-00-3
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
Trevena Inc.
|
| gptkbp:hasMolecularFormula |
C49H68N14O10
|
| https://www.w3.org/2000/01/rdf-schema#label |
TRV027
|
| gptkbp:intendedUse |
treatment of acute heart failure
|
| gptkbp:mechanismOfAction |
angiotensin II type 1 receptor biased ligand
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
angiotensin II type 1 receptor
|
| gptkbp:bfsParent |
gptkb:Trevena
|
| gptkbp:bfsLayer |
7
|